The Wall Street Journal reported today that Dr. Curt D. Furberg, a professor at Wake Forest University, was booted from an FDA committee to review the safety of the Cox-2 inhibitors after he made public statements questioning the safety of Bextra, a Cox-2 inhibitor painkiller produced by Pfizer, Inc. Vioxx, another Cox-2 inhibitor, was recently pulled from the market after it was found to increase the chance of heart-attack or stroke. Furberg, a leading expert on drug analysis, told the New York Times that he believed Bextra appeared to be similar to Vioxx.